On June 17, 2025, the Editorial Office of Ageing and Cancer Research & Treatment (ACRT) had the honor of interviewing Professor Hans-Georg Rammensee, a distinguished Advisory Editor of the journal and a globally recognized expert in tumor immunology from the University of Tübingen, Germany.

As one of the founding figures in German cancer immunology, Professor Rammensee has spent decades shaping our understanding of antigen presentation and spearheading the development of personalized cancer vaccines.

In this in-depth conversation, he shared his motivation and process of devoting himself to cancer immunity, as well as the many experiences he witnessed with patients while working in the hospital, which sparked his interest. He also analyzed the obstacles encountered in clinical practice in the future of cancer immunity. When talking about his achievements, Professor Rammensee talked about his efforts and some brilliant achievements in T-cell. Then, he talked about two mentors in his student career and gave some valuable advice to young scholars.

About Professor Hans-Georg Rammensee

A pioneer of T-cell immunology and mRNA vaccine development
Chair Professor and Head of the Department of Immunology at the University of Tübingen

The Editorial Office of Ageing and Cancer Research & Treatment sincerely thanks Prof. Rammensee for his time, expertise, and invaluable contributions to this conversation. We look forward to sharing more thought-provoking interviews with leaders in ageing and cancer research in the months ahead.